ASH elects four executive committee members

ASH elected four new members to its executive committee, the organization’s governing body.

Kenneth C. Anderson, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president. Anderson is director of the Lebow Institute for Myeloma Therapeutics and the Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute. He also serves as Kraft family professor of medicine and vice chair of the Joint Program in Transfusion Medicine at Harvard Medical School.

Susan B. Shurin, MD, will serve a 4-year term as treasurer. Shurin is senior adviser to the Center for Global Health of the NCI. She has served as deputy director and acting director of the National Heart, Lung, and Blood Institute.

Mary C. Dinauer, MD, PhD, and Terry B. Gernsheimer, MD, will both serve 4-year terms as councillors.

Dinauer is the Fred M. Saigh distinguished chair in pediatric research, professor of pediatrics, and professor of pathology and immunology at Washington University School of Medicine in St. Louis. She also is scientific director at the Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital.

Gernsheimer is medical director of the Platelet Immunology Laboratory at Puget Sound Blood Center, medical director of transfusion at Seattle Cancer Care Alliance, and assistant medical director of clinical transfusion service at the University of Washington Medical Center. She also serves as professor of medicine in the division of hematology and adjunct professor of laboratory medicine at the University of Washington.

Their terms will begin after the ASH Annual Meeting, scheduled for Dec. 6-9 in San Francisco.

“The field of hematology is changing rapidly around us — from the way we educate trainees to the way we deliver care at the patient bedside. These changes present opportunities and challenges that must be met by visionary leadership,” Linda J. Burns, MD, ASH president and director of the hematologic malignancy/bone marrow transplantation teams at the University of Minnesota’s Masonic Cancer Center, said in a press release. “Drs. Anderson, Shurin, Dinauer, and Gernsheimer bring vast knowledge and diverse experience to address these opportunities and challenges, and we look forward to working with them to help further the society’s mission to conquer blood diseases worldwide.”